Flow-metabolism uncoupling in the cervical spinal cord of ALS patients.
Flow-metabolism uncoupling in the cervical spinal cord of ALS patients.
复制标题
ALS 患者颈脊髓的血流代谢解偶联。
DOI:
10.1007/s10072-017-2823-y
复制
发表时间:
2017
期刊:
影响因子:
--
通讯作者:
Abe K.
中科院分区:
文献类型:
--
作者:
Yamashita T;Hatakeyama T;Sato K;Fukui Y;Hishikawa N;Ohta Y;Nishiyama Y;Kawai N;Tamiya T;Abe K.
Amyotrophic lateral sclerosis (ALS) is a fatal motor neuron disease. In ALS, both glucose consumption and neuronal intensity reportedly decrease in the cerebral motor cortex when measured by positron emission tomography (PET). In this study, we evaluated cervical spinal glucose metabolism, blood flow, and neuronal intensity of 10 ALS patients with upper extremity (U/E) atrophy both with18F-2-fluoro-2-deoxy-d-glucose (18F-FDG) PET and11C-flumazenil (11C-FMZ) PET. On the ipsilateral side of C5 and T1 levels,18F-FDG uptake increased significantly (*p< 0.05), and was correlated with the rate of progression of the ALS FRS-R-U/E score (R= 0.645, *p= 0.041). Despite this hyperglucose metabolism, the11C-FMZ PET study did not show a coupled increase of spinal blood flow even though neuronal intensity did not decrease. These results indicate a strong correlation between hyperglucose metabolism and ALS progression alongside the uncoupling of flow-metabolism. This mechanism, which could result in subsequent motor neuronal death, may be a potential therapeutic target for ALS.